The role of malignancies in patients with catastrophic anti-phospholipid (Asherson’s) syndrome.

MLA

Miesbach, W., et al. “The Role of Malignancies in Patients with Catastrophic Anti-Phospholipid (Asherson’s) Syndrome.” Clinical Rheumatology, vol. 26, no. 12, Dec. 2007, pp. 2109–14. EBSCOhost, https://doi.org/10.1007/s10067-007-0634-x.

APA

Miesbach, W., Asherson, R. A., Cervera, R., Shoenfeld, Y., Puerta, J. G., Espinosa, G., & Bucciarelli, S. (2007). The role of malignancies in patients with catastrophic anti-phospholipid (Asherson’s) syndrome. Clinical Rheumatology, 26(12), 2109–2114. https://doi.org/10.1007/s10067-007-0634-x

Chicago

Miesbach, W., R. A. Asherson, R. Cervera, Y. Shoenfeld, J. Gomez Puerta, G. Espinosa, and S. Bucciarelli. 2007. “The Role of Malignancies in Patients with Catastrophic Anti-Phospholipid (Asherson’s) Syndrome.” Clinical Rheumatology 26 (12): 2109–14. doi:10.1007/s10067-007-0634-x.